Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Cardiology Interventional Radiology Neurology Optometry Pain Management Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Log In

The Emerging Potential of Cannabinoids of Dermatology

By: Adam Friedman, MD

Webinar Credits: 0.75

Expiration Date: Friday, October 01, 2021
Release Date: September 21, 2020

Learning Objectives

After this activity, the learner should be able to:

  • Identify uses for cannibinoids in dermatology
  • Consider cannabinoids for patients with itch and pain related to dermatologic conditions

Accreditation and Designation Statement

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC, the Dermatology Education Foundation, and Physician Resources, LLC. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
Evolve Medical Education, LLC designates this enduring material for a maximum of .75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PAs may claim a maximum of .75 Category 1 credits for completing this activity. National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.

The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Faculty and Disclosures

It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Adam Friedman, MD, FAAD and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aveeno, Dermira, Janssen, La Roche Posay, Microcures, Novartis and Zylo.  Grant/Research Support: Almiral, Janssen and Pfizer. Speaker’s Bureau: AbbVie, Irp, and Regeneron Pharmaceuticals.  Stock/Shareholder: Microcures, and Zylo.

The staff and planners from Evolve Medical Education and Physician Resources have no financial agreement or affiliations with commercial interests.



Step 1 of 2

  • AgreeNeutralDisagree
    Identify uses for cannibinoids in dermatology
    Consider cannabinoids for patients with itch and pain related to dermatologic conditions